Genmab | Resultado Líquido



Net Income Alterar Data
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Almirall EUR 26.58M 4.98M 2025-06
Amarin USD -15697000 32.92M 2025-03
Amgen USD 1.43B 298M 2025-06
argenx SE USD 245.36M 75.89M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Bayer EUR -199000000 1.5B 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Demant DKK 1.12B 71M 2025-06
Exelixis USD 230.42M 70.8M 2025-07
Fresenius Medical Care EUR 225M 74M 2025-06
Galapagos EUR -105748000 47.66M 2025-06
Genmab DKK 336M 141M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
GN Store Nord DKK 165M 94M 2025-06
GRIFOLS EUR 117.06M 57.34M 2025-06
Hikma Pharmaceutical USD 133M 93M 2024-12
Insmed USD -321686000 65.1M 2025-06
Lonza CHF 307M 22M 2024-12
Merck EUR 652M 83M 2025-06
Novartis USD 4.02B 418M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
UCB EUR 857M 649M 2024-12


Genmab Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.